← DocG Medical Summaries

Top Infectious Disease Research Papers

Live ranking — trailing 6 months, each paper's latest score Scores fold Infectious Disease Relevance & Applicability into the quality dimensions; papers scored before the dynamic-specialty rubric keep their original score Showing the top 10 of 447 ranked articles — sign in free for the full ranking and per-criterion score breakdowns
1. 8.6
Short or Long Antibiotic Regimens in Orthopedics.
Overall: A strong randomized trial shows that markedly shorter systemic antibiotic therapy after local antibiotic implantation preserves clinical outcomes while substantially reducing treatment-related symptoms and burden.
2. 8.0
RSV Immunization Effectiveness and Safety for the 2026-2027 Respiratory Season.
Overall: This broad, US-focused evidence review supports substantial protection against severe RSV with reassuring comparative safety findings, although heterogeneous designs, imprecise subgroup estimates, absent absolute effects, and largely confirmatory conclusions limit certainty and novelty.
3. 8.0
High-Dose vs Standard-Dose Influenza Vaccines in Older Adults: A Meta-Analysis.
Overall: High-Dose vs Standard-Dose Influenza Vaccines in Older Adults: A Meta-Analysis provides strong, precise, and directly applicable evidence that high-dose vaccination reduces hospitalization outcomes in older adults, though absolute benefits, adverse effects, and mortality improvement are not demonstrated.
4. 8.0
Effectiveness of Nirmatrelvir/Ritonavir for Outpatients in the Era of Omicron, Vaccination, and Previous Infection: A Meta-analysis.
Overall: This large contemporary meta-analysis supports meaningful reductions in hospitalization and death with nirmatrelvir-ritonavir among higher-risk outpatients, although reliance on observational studies and absent harm data limit certainty.
5. 7.9
Sustained benefit of compression therapy for preventing recurrent leg cellulitis: extended follow-up of a randomised controlled trial.
Overall: This small but well-conducted randomized trial found a large, durable reduction in recurrent cellulitis and hospitalization with a practical intervention, though its open-label single-center design and unreported harms limit certainty.
6. 7.8
COVID-19 Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season.
Overall: This broad US-focused systematic review reports substantial reductions in serious, patient-important COVID-19 outcomes without new safety signals, although reliance on heterogeneous observational evidence and absent absolute effects limit certainty and novelty.
7. 7.7
Respiratory Syncytial Virus Vaccine Effectiveness Among US Older Adults, 2023-2024 Season.
Overall: Respiratory Syncytial Virus Vaccine Effectiveness Among US Older Adults, 2023-2024 Season: A very large US cohort found strong protection against hospitalization and death, but its observational design, unreported adjustment details, and lack of absolute benefits or harms temper certainty.
8. 7.7
Single- vs Multiple-Dose Antibiotic Prophylaxis for Total Hip Arthroplasty.
Overall: A very large, carefully analyzed observational cohort supports simple single-dose prophylaxis without increased infection, but residual confounding and lack of randomized confirmation temper the conclusion.
9. 7.7
Respiratory Syncytial Virus Vaccine Effectiveness in Medicare Beneficiaries Residing in Nursing Homes.
Overall: This large US observational study reports substantial RSV vaccine effectiveness against major clinical outcomes in nursing-home residents, but claims-based ascertainment, residual confounding, and absent absolute benefit and safety data temper confidence.
10. 7.6
Effectiveness of RSV Prevention Strategies in US Infants: 2024-2025.
Overall: This multicenter US observational study provides credible, clinically important evidence that both recommended RSV prevention strategies reduce infant emergency visits and hospitalizations, though residual confounding and absent absolute benefit and safety data limit certainty.
Score Guide: 9-10 Exceptional 7-8 Strong 5-6 Moderate 3-4 Weak 1-2 Poor

Get the top Infectious Disease papers in your inbox

Free 300-word clinical summaries 3× per week, plus the full ranking of all 447 recent Infectious Disease papers with per-criterion AI score breakdowns.

Sign Up Free